Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – According to the World Health...
Jefferies analysts have set the S&P 500 (SNPINDEX: ^GSPC) with a 2025 target of 6,000. That forecast implies about 1% downside from its current level of 6,050, which ranks among the most bearish outlooks...
These two biotech companies look poised to deliver in the coming year.
GRANT PICKERING, the CHIEF EXECUTIVE OFFICER of $PCVX ($PCVX), sold 222 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.2%...
Mikhail Eydelman, the SVP of $PCVX ($PCVX), sold 1,435 shares of the company on 12-05-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.3% of their shares....
Jim Wassil, the CHIEF OPERATING OFFICER of $PCVX ($PCVX), sold 1,101 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.5% of...
GRANT PICKERING, the CHIEF EXECUTIVE OFFICER of $PCVX ($PCVX), sold 2,242 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.5%...
Vaxcyte initiates Phase 2 study for VAX-31, targeting enhanced protection against pneumococcal disease in infants. Topline data expected by mid-2026.Quiver AI SummaryVaxcyte, Inc. has initiated a Phase...
In general, the S&P 500 (SNPINDEX: ^GSPC) is the preferred stock market barometer for large-cap companies, while the Russell 2000 is the preferred stock market barometer for small-cap companies. Specific...